SynthesisBreast cancer research and treatment2026

Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis.

Lorrany Larisse Costa Rodrigues et al.PubMed ↗Publisher ↗

No numbers read from the abstract.